COMPLIANCE STATEMENT FOR RELEASE

The following lot of Covid-19 Vaccine AstraZeneca Solution for Injection

(Coronavirus(SARS-CoV-2) vaccine (recombinant monkey adenovirus vector))
produced by Daiichi Sankyo Biotech Co., Ltd., Japan, whose numbers appears
on the labels of the final containers, is comparable and conform to the same
quality standard as COVID-19 Vaccine AstraZeneca Solution for Injection
registered in Malaysia.

As a minimum, the release is based on recognition of the batch release certificate

issued by regulatory authority of the releasing country and assessment on the
cold chain requirement.

Lot no: D004A

Expiry date: 6 October 2021
No. of doses: 998,400
No. of doses per container: 10

Signature:

Name of authorized person: NIK JUZAIMAH BINTI JUHARI

Head of Product and Cosmetic Testing Section
for Director of National Pharmaceutical Regulatory Agency (NPRA)
Ministry of Health Malaysia

Date: 2 July 2021